About Sharon Tetlow
Form D filings for Cessation Therapeutics in 2024 list Sharon Tetlow as director.
Sharon Tetlow first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Sharon Tetlow in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sharon Tetlow works with at each company, as listed on that company's latest Form D.
Cessation Therapeutics, Inc. · Form D, Apr 3, 2024